DNA copy number alterations in prostate cancers: a combined analysis of published CGH studies
- PMID: 17342750
- DOI: 10.1002/pros.20543
DNA copy number alterations in prostate cancers: a combined analysis of published CGH studies
Abstract
Background: Identifying genomic regions that are commonly deleted or gained in neoplastic cells is an important approach to identify tumor suppressor genes and oncogenes. Studies in the last two decades have identified a number of common DNA copy number alterations in prostate cancer. However, because of various sample sizes, diverse tumor types and sources, as well as a variety of detection methods with various sensitivities and resolutions, it is difficult to summarize and fully interpret the overall results.
Methods: We performed a combined analysis of all published comparative genomic hybridization (CGH) studies of prostate cancer and estimated the frequency of alterations across the genome for all tumors, as well as in advanced and localized tumors separately. A total of 41 studies examining 872 cancers were included in this study.
Results: The frequency of deletions and gains were estimated in all tumors, as well as in advanced and localized tumors. Eight deleted and five gained regions were found in more than 10% of the prostate tumors. An additional six regions were commonly deleted and seven were commonly gained in advanced tumors. While 8p was the most common location of deletion, occurring in about a third of all tumors and about half of advanced tumors, 8q was the most commonly gained region, affecting about a quarter of all tumors and about half of all advanced tumors.
Conclusions: The large number of tumors examined in this combined analysis provides better estimates of the frequency of specific alterations in the prostate cancer cell genome, and offers important clues for prioritizing efforts to identify tumor suppressor genes and oncogenes in these altered regions.
(c) 2007 Wiley-Liss, Inc.
Similar articles
-
Genetic aberrations in prostate carcinoma detected by comparative genomic hybridization and microsatellite analysis: association with progression and angiogenesis.Prostate. 2004 Apr 1;59(1):43-58. doi: 10.1002/pros.20028. Prostate. 2004. PMID: 14991865
-
Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization.Cancer Res. 1995 Jan 15;55(2):342-7. Cancer Res. 1995. PMID: 7529134
-
Simultaneously detection of genomic and expression alterations in prostate cancer using cDNA microarray.Prostate. 2008 Oct 1;68(14):1496-509. doi: 10.1002/pros.20756. Prostate. 2008. PMID: 18366025
-
[Analysis of genomic copy number alterations of malignant lymphomas and its application for diagnosis].Gan To Kagaku Ryoho. 2007 Jul;34(7):975-82. Gan To Kagaku Ryoho. 2007. PMID: 17637530 Review. Japanese.
-
Tumor suppressor genes in prostatic oncogenesis.J Cell Biochem Suppl. 1994;19:217-23. J Cell Biochem Suppl. 1994. PMID: 7823594 Review.
Cited by
-
Urine cell-free DNA integrity as a marker for early prostate cancer diagnosis: a pilot study.Biomed Res Int. 2013;2013:270457. doi: 10.1155/2013/270457. Epub 2013 Feb 13. Biomed Res Int. 2013. PMID: 23509700 Free PMC article.
-
Genetic and epigenetic inactivation of TNFRSF10C in human prostate cancer.Prostate. 2009 Feb 15;69(3):327-35. doi: 10.1002/pros.20882. Prostate. 2009. PMID: 19035483 Free PMC article.
-
Frequent heterogeneous missense mutations of GGAP2 in prostate cancer: implications for tumor biology, clonality and mutation analysis.PLoS One. 2012;7(2):e32708. doi: 10.1371/journal.pone.0032708. Epub 2012 Feb 28. PLoS One. 2012. PMID: 22389719 Free PMC article.
-
Activation of the PI3K pathway in cancer through inhibition of PTEN by exchange factor P-REX2a.Science. 2009 Sep 4;325(5945):1261-5. doi: 10.1126/science.1173569. Science. 2009. PMID: 19729658 Free PMC article.
-
Single and multivariate associations of MSR1, ELAC2, and RNASEL with prostate cancer in an ethnic diverse cohort of men.Cancer Epidemiol Biomarkers Prev. 2010 Feb;19(2):588-99. doi: 10.1158/1055-9965.EPI-09-0864. Epub 2010 Jan 19. Cancer Epidemiol Biomarkers Prev. 2010. PMID: 20086112 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical